Timothy Kocses

Executive Director, US Pharmaceuticals Finance Controller at Bristol Myers Squibb

Tim joined BMS in July 2013, and is currently Executive Director, Technical Accounting & Policy and leads the global Technical Accounting Network (“TAN”) within the organization. In his role, he:

• Supports the Corporate Financial Reporting (“CFR”) group on technical accounting matters,
• Oversees and advises on financial accounting policies.
• Leads BMS’ adoption and implementation efforts for significant accounting changes
• Overseas global revenue recognition in accordance with ASC 606.
• Helps drive accounting process improvements and efficiencies
• Provides the technical accounting expertise on all Business Development transactions (including mergers, acquisitions, divestitures, in - licenses, outlicense, equity transactions, venture capital investments and R&D option and financing transactions.)
• Leads global accounting for integration, restructuring, site rationalization and leases
• Overseas the goodwill & intangible asset impairment processes
• Leads the Non - GAAP Specified Items Committee Reporting team.
• Manages the BMS’ Accounting Development Program (“ADP”) of 15 professionals

Prior to joining BMS, Tim worked for KPMG LLP (“KPMG”) in the New Jersey audit practice from October 2002 to June 2013, serving clients primarily in the life-sciences sector.